SCHEMBL6340484

SCHEMBL6340484

O=C(NC(=O)c1ccccc1)NC(=O)c1ccccc1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 8/20 0.72
NPC1 O15118 7/20 0.72
MEN1 O00255 3/20 0.72
KMT2A Q03164 3/20 0.72
TP53 P04637 1/20 0.64
ALDH1A1 P00352 1/20 0.61
HDAC3 O15379 1/20 0.61
CA12 O43570 1/20 0.61
CA1 P00915 1/20 0.61
IDO1 P14902 1/20 0.61
ALOX15 P16050 1/20 0.61
HDAC1 Q13547 1/20 0.61
CA9 Q16790 1/20 0.61
HDAC7 Q8WUI4 1/20 0.61
HDAC2 Q92769 1/20 0.61
HSD17B10 Q99714 1/20 0.61
HDAC8 Q9BY41 1/20 0.61
HDAC6 Q9UBN7 1/20 0.61
NCOR2 Q9Y618 1/20 0.61
PKM P14618 1/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL76489 0.89 ALDH1A1 (0.67) RAB9ANPC1MEN1KMT2ATP53
SCHEMBL7048399 0.89 ALDH1A1 (0.62) RAB9ANPC1MEN1KMT2ATP53
Hydrochloric Acid SCHEMBL27693713 0.86 ALDH1A1 (0.64) RAB9ANPC1MEN1KMT2ATP53
SCHEMBL27694024 0.86 RAB9A (0.62) RAB9ANPC1MEN1KMT2ATP53
SCHEMBL6972053 0.86 RAB9A (0.62) RAB9ANPC1MEN1KMT2ATP53
SCHEMBL11563459 0.86 RAB9A (0.62) RAB9ANPC1MEN1KMT2ATP53
SCHEMBL4762280 0.86 RAB9A (0.62) RAB9ANPC1MEN1KMT2ATP53
SCHEMBL28751320 0.85 RAB9A (0.56) RAB9ANPC1MEN1KMT2ATP53
SCHEMBL4684343 0.84 RAB9A (1.00) RAB9ANPC1MEN1KMT2ATP53
SCHEMBL1005988 0.84 ALDH1A1 (0.61) RAB9ANPC1MEN1KMT2ATP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2954978-B1 CORE/SHELL-TYPE INORGANIC PARTICLES KONICA MINOLTA INC (JP) 2020-05-20 EP disclosed
CN-109761844-A A kind of method that one kettle way prepares 1- (4- benzamido-phenyl) -3- phenyl-propane -1,3- diketone 常州南京大学高新技术研究院 2019-05-17 CN disclosed
US-10011752-B2 Production method for polishing-material particles Konica Minolta, Inc. (JP) 2018-07-03 US disclosed
US-20180044198-A1 SPHERICAL ZINC OXIDE PARTICLES, PROCESS FOR PRODUCING SAME, AND PLASMON SENSOR CHIP OBTAINED USING SAME Konica Minolta, Inc. (JP) 2018-02-15 US disclosed
US-9868885-B2 Polishing material particles, method for producing polishing material, and polishing processing method Konica Minolta, Inc. (JP) 2018-01-16 US disclosed
US-9850413-B2 Abrasive particles and production method thereof Konica Minolta, Inc. (JP) 2017-12-26 US disclosed
US-20160272860-A1 Cerium Oxide Abrasive, Method for Producing Cerium Oxide Abrasive, and Polishing Method Konica Minolta, Inc. (JP) 2016-09-22 US disclosed
US-20160194538-A1 Polishing Material Particles, Method For Producing Polishing Material, And Polishing Processing Method Konica Minolta, Inc. (JP) 2016-07-07 US disclosed
US-20160194539-A1 Polishing Material, Polishing Material Slurry Konica Minolta, Inc. (JP) 2016-07-07 US disclosed
US-9222009-B2 Fine abrasive particles and method for producing same Konica Minolta, Inc. (JP) 2015-12-29 US disclosed
US-20150252237-A1 Method for Producing Polishing Material Particles Konica Minolta, Inc. (JP) 2015-09-10 US disclosed
US-20150232728-A1 Production Method For Polishing-Material Particles Konica Minolta, Inc. (JP) 2015-08-20 US disclosed
US-20150175864-A1 Abrasive Particles And Production Method Thereof Konica Minolta, Inc. (JP) 2015-06-25 US disclosed
US-20150174734-A1 Polishing Material Composition And Production Method Therefor Konica Minolta, Inc. (JP) 2015-06-25 US disclosed
US-20130305618-A1 Fine Abrasive Particles and Process for Producing Same Konica Minolta, Inc. (JP) 2013-11-21 US disclosed
US-6946554-B2 Process for the preparation of 9-deazaguanine derivatives BIOCRYST PHARMACEUTICALS, INC. (US) 2005-09-20 US disclosed
CN-1558897-A oral antidiabetic agent ����-�����ع�˾ 2004-12-29 CN disclosed
US-20040254181-A1 Process for the preparation of 9-deazaguanine derivatives BIOCRYST PHARMACEUTICALS, INC. 2004-12-16 US disclosed
JP-2004217572-A COMPOUND USEFUL AS NEW LOW MOLECULAR ORGANIC GELLING OR SOLIDIFYING AGENT, AND GELLING OR SOLIDIFYING AGENT CONTAINING THE COMPOUND AS AN ACTIVE INGREDIENT AND GELLED OR SOLIDIFIED PRODUCT JAPAN SCIENCE & TECHNOLOGY AGENCY 2004-08-05 JP disclosed
US-4977189-A Anxiolytic agents, cognition activators AMERICAN CYANAMID COMPANY (US) 1990-12-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040254181-A1 Process for the preparation of 9-deazaguanine derivatives ALKBH3, ALKBH2, ALKBH1 RAB9A 387/4885NPC1 4609/4885MEN1 2978/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.